EZH2 and metabolic dysfunction-associated steatotic liver disease: In hepatocellular carcinoma associated with non-alcoholic fatty liver disease, YTHDF1 can directly target EZH2 mRNA to promote EZH2 translation, leading to the production of cytokine IL-6 in tumor cells.